




Instance: composition-en-91e2d101c3ad773f6da87d4465331140
InstanceOf: CompositionUvEpi
Title: "Composition for enurev Package Leaflet"
Description:  "Composition for enurev Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mp29cfa45e92e84ebeea3fcb2b59136717)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - enurev"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is in this leaflet</p>
<ol>
<li>What Enurev Breezhaler is and what it is used for </li>
<li>What you need to know before you use Enurev Breezhaler </li>
<li>How to use Enurev Breezhaler </li>
<li>Possible side effects </li>
<li>How to store Enurev Breezhaler </li>
<li>Contents of the pack and other information </li>
</ol>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What enurev is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What enurev is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What Enurev Breezhaler is 
This medicine contains an active substance called glycopyrronium bromide. This belongs to a group of 
medicines called bronchodilators. </p>
<p>What Enurev Breezhaler is used for 
This medicine is used to make breathing easier for adult patients who have breathing difficulties due to 
a lung disease called chronic obstructive pulmonary disease (COPD). </p>
<p>In COPD the muscles around the airways tighten. This makes breathing difficult. This medicine blocks 
the tightening of these muscles in the lungs, making it easier for air to get in and out of the lungs. </p>
<p>If you use this medicine once a day, it will help to reduce the effects of COPD on your everyday life. </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take enurev"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take enurev"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Do not use Enurev Breezhaler 
- if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine 
(listed in section 6). </p>
<p>Warnings and precautions 
Talk to your doctor before using Enurev Breezhaler, if any of the following applies to you:</p>
<ul>
<li>you have kidney problems. </li>
<li>you have an eye problem called narrow-angle glaucoma. </li>
<li>you have difficulty passing urine. </li>
</ul>
<p>During treatment with Enurev Breezhaler, stop taking this medicine and tell your doctor 
immediately:</p>
<ul>
<li>if you experience tightness of the chest, coughing, wheezing or breathlessness immediately after 
using Enurev Breezhaler (signs of bronchospasm). </li>
<li>if you experience difficulties in breathing or swallowing, swelling of the tongue, lips or face, 
skin rash, itching and hives (signs of allergic reaction). </li>
<li>if you experience eye pain or discomfort, temporary blurring of vision, visual halos or coloured 
images in association with red eyes. These may be signs of an acute attack of narrow-angle 
glaucoma. </li>
</ul>
<p>Enurev Breezhaler is used as a maintenance treatment for your COPD. Do not use this medicine to 
treat a sudden attack of breathlessness or wheezing. </p>
<p>Children and adolescents 
Do not give this medicine to children or adolescents below the age of 18 years. </p>
<p>Other medicines and Enurev Breezhaler 
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other 
medicines. This includes medicines similar to Enurev Breezhaler used for your lung disease, such as 
ipratropium, oxitropium or tiotropium (so called anticholinergics). </p>
<p>No specific side effects have been reported when Enurev Breezhaler has been used together with other 
medicines used to treat COPD such as reliever inhalers (e.g. salbutamol), methylxanthines (e.g. 
theophylline) and/or oral and inhaled steroids (e.g. prednisolone). </p>
<p>Pregnancy, breast-feeding and fertility 
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask 
your doctor or pharmacist for advice before taking this medicine. </p>
<p>There are no data from the use of this medicine in pregnant women and it is not known whether the 
active substance of this medicine passes into human milk. </p>
<p>Driving and using machines 
It is unlikely that this medicine will affect your ability to drive and use machines. </p>
<p>Enurev Breezhaler contains lactose 
This medicine contains lactose. If you have been told by your doctor that you have an intolerance to 
some sugars, contact your doctor before taking this medicine. </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take enurev"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take enurev"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor 
or pharmacist if you are not sure. </p>
<p>How much Enurev Breezhaler to use 
The usual dose is to inhale the content of one capsule each day. 
You only need to inhale once a day because the effect of this medicine lasts for 24 hours. 
Do not use more than your doctor tells you to use. </p>
<p>Elderly people 
You can use this medicine if you are aged 75 years and over at the same dose as for other adults. </p>
<p>When to inhale Enurev Breezhaler 
Use this medicine at the same time each day. This will also help you to remember to use it. </p>
<p>You can inhale this medicine anytime before or after food or drink. </p>
<p>How to inhale Enurev Breezhaler 
- In this pack, you will find an inhaler and capsules (in blisters) that contain the medicine as 
inhalation powder. Only use the capsules with the inhaler provided in this pack (Enurev 
Breezhaler inhaler). The capsules should remain in the blister until you need to use them. 
- Do not push the capsule through the foil. 
- When you start a new pack, use the new Enurev Breezhaler inhaler that is supplied in the pack. 
- Dispose of each inhaler after after all capsules in that pack have been used. 
- Do not swallow the capsules. 
- Please read the instructions at the end of this leaflet for more information on how to use the 
inhaler. </p>
<p>If you use more Enurev Breezhaler than you should 
If you have inhaled too much of this medicine or if someone else accidentally uses your capsules, you 
must immediately either tell your doctor or go to the nearest emergency unit. Show the pack of Enurev 
Breezhaler. Medical attention may be needed. </p>
<p>If you forget to use Enurev Breezhaler 
If you forget to inhale a dose, take one as soon as possible. However, do not take two doses on the 
same day. Then take the next dose as usual. </p>
<p>How long to continue your treatment with Enurev Breezhaler 
- Keep using this medicine for as long as your doctor tells you. 
- COPD is a long-term disease and you should use this medicine every day and not only when 
you have breathing problems or other symptoms of COPD. 
If you have questions about how long to continue your treatment with this medicine, talk to your 
doctor or pharmacist. </p>
<p>If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. </p>
<p>Some side effects may be serious but are uncommon 
(may affect up to 1 in 100 people) 
* Irregular heart beat 
* High level of blood sugar (hyperglycaemia: typical symptoms include excessive thirst or hunger 
and frequent urination) 
* Rash, itching, hives, difficulty breathing or swallowing, dizziness (possible signs of allergic 
reaction) 
* Swelling mainly of the tongue, lips, face or throat (possible signs of angioedema) 
If you get any of these side effects, tell your doctor immediately. </p>
<p>Some side effects may be serious, but the frequency of these side effects is not known 
(frequency cannot be estimated from the available data) 
* Difficulty breathing with wheezing or coughing (signs of paradoxical bronchospasm) </p>
<p>Some side effects are common 
(may affect up to 1 in 10 people) 
* Dry mouth 
* Difficulty sleeping 
* Runny or stuffy nose, sneezing, sore throat 
* Diarrhoea or stomach ache 
* Musculoskeletal pain </p>
<p>Some side effects are uncommon 
(may affect up to 1 in 100 people) 
* Difficulty and pain when passing urine 
* Painful and frequent urination 
* Palpitations 
* Rash 
* Numbness 
* Cough with sputum 
* Dental caries 
* Feeling of pressure or pain in the cheeks and forehead 
* Nose bleeds 
* Pain in arms or legs 
* Pain in muscles, bones or joints of the chest 
* Stomach discomfort after meals 
* Throat irritation 
* Tiredness 
* Weakness 
* Itching 
* Voice alteration (hoarseness) 
* Nausea 
* Vomiting </p>
<p>Some elderly patients above 75 years of age experienced headache (frequency common) and urinary 
tract infection (frequency common). </p>
<p>Reporting of side effects 
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects 
not listed in this leaflet. You can also report side effects directly via the national reporting system 
listed in Appendix V. By reporting side effects you can help provide more information on the safety of 
this medicine. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store enurev"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store enurev"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this medicine out of the sight and reach of children. </p>
<p>Do not use this medicine after the expiry date which is stated on the carton and blister after  EXP . 
The expiry date refers to the last day of that month. </p>
<p>Do not store above 25 C. </p>
<p>Store the capsules in the original blister in order to protect from moisture. Do not remove from the 
blister until immediately before use. </p>
<p>The inhaler in each pack should be disposed of after all capsules in that pack have been used. </p>
<p>Do not use this medicine if you notice that the pack is damaged or shows signs of tampering. </p>
<p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to 
throw away medicines you no longer use. These measures will help protect the environment. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What Enurev Breezhaler contains 
- The active substance is glycopyrronium bromide. Each capsule contains 63 micrograms of 
glycopyrronium bromide (equivalent to 50 micrograms glycopyrronium). The delivered dose 
(the dose that leaves the mouthpiece of the inhaler) is equivalent to 44 micrograms of 
glycopyrronium. 
- The other ingredients of the inhalation powder are lactose monohydrate and magnesium 
stearate. </p>
<p>What Enurev Breezhaler looks like and contents of the pack 
Enurev Breeyhaler 44 micrograms inhalation powder, hard capsules are transparent and orange and 
contain a white powder. They have the product code  GPL50  printed in black above and a company 
logo (
) printed in black below a black bar. </p>
<p>Each pack contains a device called an inhaler, together with capsules in blisters. Each blister strip 
contains either 6 or 10 hard capsules. </p>
<p>The following pack sizes are available: 
Packs containing 6x1, 10x1, 12x1 or 30x1 hard capsules, together with one inhaler. </p>
<p>Multipacks containing 90 (3 packs of 30x1) hard capsules and 3 inhalers. 
Multipacks containing 96 (4 packs of 24x1) hard capsules and 4 inhalers. 
Multipacks containing 150 (15 packs of 10x1) hard capsules and 15 inhalers. 
Multipacks containing 150 (25 packs of 6x1) hard capsules and 25 inhalers. </p>
<p>Not all pack sizes may be available in your country. </p>
<p>Marketing Authorisation Holder 
Novartis Europharm Limited 
Vista Building 
Elm Park, Merrion Road 
Dublin 4 
Ireland </p>
<p>Manufacturer 
Novartis Farmac utica SA 
Gran Via de les Corts Catalanes, 08013 Barcelona 
Spain </p>
<p>Novartis Pharma GmbH 
Roonstra e D-90429 Nuremberg 
Germany </p>
<p>For any information about this medicine, please contact the local representative of the Marketing 
Authorisation Holder: </p>
<p>Belgi /Belgique/Belgien 
Novartis Pharma N.V. 
T l/Tel: +32 2 246 16 Lietuva 
SIA Novartis Baltics Lietuvos filialas 
Tel: +370 5 269 16 <br />
Novartis Bulgaria EOOD 
 .: +359 2 489 98 Luxembourg/Luxemburg 
Novartis Pharma N.V. 
T l/Tel: +32 2 246 16  esk  republika 
Novartis s.r.o. 
Tel: +420 225 775 Magyarorsz g 
Novartis Hung ria Kft. 
Tel.: +36 1 457 65 Danmark 
Novartis Healthcare A/S 
Tlf: +45 39 16 84 Malta 
Novartis Pharma Services Inc. 
Tel: +356 2122 2Deutschland 
Novartis Pharma GmbH 
Tel: +49 911 273 0 </p>
<p>Nederland 
Novartis Pharma B.V. 
Tel: +31 88 04 52 Eesti 
SIA Novartis Baltics Eesti filiaal 
Tel: +372 66 30 Norge 
Novartis Norge AS 
Tlf: +47 23 05 20 <br />
Novartis (Hellas) A.E.B.E. 
 : +30 210 281 17  sterreich 
Novartis Pharma GmbH 
Tel: +43 1 86 6Espa a 
Ferrer Internacional, S.A. 
Tel: +34 93 600 37 Polska 
Novartis Poland Sp. z o.o. 
Tel.: +48 22 375 4France 
Novartis Pharma S.A.S. 
T l: +33 1 55 47 66 Portugal 
Novartis Farma - Produtos Farmac uticos, S.A. 
Tel: +351 21 000 8Hrvatska 
Novartis Hrvatska d.o.o. 
Tel. +385 1 6274 Rom nia 
Novartis Pharma Services Romania SRL 
Tel: +40 21 31299 Ireland 
Novartis Ireland Limited 
Tel: +353 1 260 12 Slovenija 
Novartis Pharma Services Inc. 
Tel: +386 1 300 75  sland 
Vistor hf. 
S mi: +354 535 7Slovensk  republika 
Novartis Slovakia s.r.o. 
Tel: +421 2 5542 5Italia 
Novartis Farma S.p.A. 
Tel: +39 02 96 54 1 
Suomi/Finland 
Novartis Finland Oy 
Puh/Tel: +358 (0)10 6133 <br />
Novartis Pharma Services Inc. 
 : +357 22 690 Sverige 
Novartis Sverige AB 
Tel: +46 8 732 32 Latvija 
SIA Novartis Baltics 
Tel: +371 67 887 United Kingdom (Northern Ireland) 
Novartis Ireland Limited 
Tel: +44 1276 698This leaflet was last revised in </p>
<p>Other sources of information 
Detailed information on this medicine is available on the European Medicines Agency website: 
http://www.ema.europa.eu </p>
<p>Instructions for use of Enurev Breezhaler inhaler </p>
<p>Please read the full Instructions for Use before using the Enurev Breezhaler. </p>
<p>Insert 
Pierce and release 
Inhale deeply 
Check capsule is empty </p>
<p>Step 1a: 
Pull off cap 
Step 2a: 
Pierce capsule once 
Hold the inhaler upright. 
Pierce capsule by firmly 
pressing both side 
buttons at the same time. 
Step 3a: 
Breathe out fully 
Do not blow into the 
inhaler. 
Check capsule is empty 
Open the inhaler to see if 
any powder is left in the 
capsule. </p>
<p>You should hear a noise 
as the capsule is pierced. 
Only pierce the capsule 
once. </p>
<p>If there is powder left in 
the capsule: 
* Close the inhaler. 
* Repeat steps 3a to 3c. 
Step 1b: 
Open inhaler </p>
<p>Step 2b: 
Release side buttons 
Step 3b: 
Inhale medicine deeply 
Hold the inhaler as 
shown in the picture. 
Place the mouthpiece in 
your mouth and close 
your lips firmly around 
it. 
Do not press the side 
buttons. </p>
<p>Powder 
Empty 
remaining 
1 </p>
<p>2 </p>
<p>3 </p>
<p>Check </p>
<p>Breathe in quickly and as 
deeply as you can. 
During inhalation you 
will hear a whirring 
noise. 
You may taste the 
medicine as you inhale. </p>
<p>Step 1c: 
Remove capsule 
Separate one of the 
blisters from the blister 
card. 
Peel open the blister and 
remove the capsule. 
Do not push the capsule 
through the foil. 
Do not swallow the 
capsule. </p>
<p>Step 3c: 
Hold breath 
Hold your breath for up 
to 5 seconds. 
Remove empty capsule 
Put the empty capsule in 
your household waste. 
Close the inhaler and 
replace the cap. </p>
<p>Step 1d: 
Insert capsule 
Never place a capsule 
directly into the 
mouthpiece. </p>
<p>Important Information 
  Enurev Breezhaler 
capsules must always be 
stored in the blister card 
and only removed 
immediately before use. 
  Do not push the capsule 
through the foil to 
remove it from the 
blister. 
  Do not swallow the 
capsule. 
  Do not use the Enurev 
Breezhaler capsules with 
any other inhaler. 
  Do not use the Enurev 
Breezhaler inhaler to 
take any other capsule 
medicine. 
  Never place the capsule 
into your mouth or the 
mouthpiece of the 
inhaler. 
  Do not press the side 
buttons more than once. 
  Do not blow into the 
mouthpiece. 
  Do not press the side 
buttons while inhaling 
through the mouthpiece. 
  Do not handle capsules 
with wet hands. 
  Never wash your inhaler 
with water. </p>
<p>Step 1e: 
Close inhaler </p>
<p>Your Seebri Breezhaler Inhaler pack contains: 
  One Seebri Breezhaler inhaler 
  One or more blister cards, each containing either 
6 or 10 Seebri Breezhaler capsules to be used in 
the inhaler </p>
<p>Frequently Asked 
Questions </p>
<p>Why didn t the inhaler 
make a noise when I 
inhaled? 
The capsule may be stuck 
in the capsule chamber. If 
this happens, carefully 
loosen the capsule by 
tapping the base of the 
inhaler. Inhale the 
medicine again by 
repeating steps 3a to 3c. </p>
<p>What should I do if there 
is powder left inside the 
capsule? 
You have not received 
enough of your medicine. 
Close the inhaler and 
repeat steps 3a to 3c. </p>
<p>I coughed after inhaling 
  does this matter? 
This may happen. As long 
as the capsule is empty 
you have received enough 
of your medicine. </p>
<p>I felt small pieces of the 
capsule on my tongue <br />
does this matter? 
This can happen. It is not 
harmful. The chances of 
the capsule breaking into 
small pieces will be 
increased if the capsule is 
pierced more than once. 
Cleaning the inhaler 
Wipe the mouthpiece 
inside and outside with a 
clean, dry, lint-free cloth to 
remove any powder 
residue. Keep the inhaler 
dry. Never wash your 
inhaler with water. 
Disposing of the inhaler 
after use 
Each inhaler should be 
disposed of after all 
capsules have been used. 
Ask your pharmacist how 
to dispose of medicines 
and inhalers that are no 
longer required. </p>
<p>Blister Card 
Blister 
Inhaler base 
Inhaler 
Base 
Cap 
Side 
buttons 
Capsule 
chamber 
Mouthpiece 
Screen </p>         </div>"""      



Instance: composition-da-91e2d101c3ad773f6da87d4465331140
InstanceOf: CompositionUvEpi
Title: "Composition for enurev Package Leaflet"
Description:  "Composition for enurev Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mp29cfa45e92e84ebeea3fcb2b59136717)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - enurev"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #da
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Oversigt over indlægssedlen </p>
<ol>
<li>Virkning og anvendelse </li>
<li>Det skal du vide, før du begynder at bruge Enurev Breezhaler </li>
<li>Sådan skal du bruge Enurev Breezhaler </li>
<li>Bivirkninger </li>
<li>Opbevaring </li>
<li>Pakningsstørrelser og yderligere oplysninger </li>
</ol>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What enurev is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What enurev is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Virkning 
Dette lægemiddel indeholder et aktivt stof, der kaldes glycopyrroniumbromid. Enurev Breezhaler 
tilhører en gruppe lægemidler, der kaldes bronkodilatorer. </p>
<p>Anvendelse 
Dette lægemiddel anvendes til at lette vejrtrækning hos voksne patienter, som lider af 
åndedrætsbesvær pga. en lungesygdom kaldet kronisk obstruktiv lungesygdom (KOL).  </p>
<p>Ved KOL trækker musklerne sig sammen omkring luftvejene. Dette gør det svært at trække vejret. 
Dette lægemiddel hindrer, at musklerne i lungerne trækker sig sammen, og gør det derved nemmere at 
trække vejret ind og ud af lungerne. </p>
<p>Hvis du tager dette lægemiddel én gang dagligt, vil det mindske påvirkningen af KOL i din dagligdag. </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take enurev"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take enurev"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Brug ikke Enurev Breezhaler 
- hvis du er allergisk over for glycopyrroniumbromid eller et af de øvrige indholdsstoffer i 
Enurev Breezhaler (angivet i punkt 6). </p>
<p>Advarsler og forsigtighedsregler 
Kontakt lægen, før du bruger Enurev Breezhaler, hvis nogen af nedenstående forhold gælder for dig:</p>
<ul>
<li>hvis du har nyreproblemer. </li>
<li>hvis du har en øjenlidelse, som kaldes snævervinklet glaukom. </li>
<li>hvis du har vandladningsbesvær. </li>
</ul>
<p>Under behandling med Enurev Breezhaler, stop med at tage medicinen og fortæl det øjeblikkeligt 
til din læge:</p>
<ul>
<li>hvis du oplever trykken for brystet, hoste, hvæsen eller åndenød umiddelbart efter, du har taget 
Enurev Breezhaler (tegn på bronkospasme). </li>
<li>hvis du oplever problemer med at trække vejret eller synke, hævelse af tunge, læber eller ansigt, 
hududslæt, kløe og nældefeber (tegn på allergisk reaktion). </li>
<li>hvis du oplever øjensmerter eller -ubehag, midlertidig sløring af synet, visuelle ringe eller farvet 
syn i forbindelse med røde øjne. Dette kan være tegn på et akut anfald af snævervinklet 
glaukom. </li>
</ul>
<p>Enurev Breezhaler anvendes som vedligeholdelsesbehandling af din KOL. Brug ikke dette lægemiddel 
til behandling af pludselige anfald af åndenød eller hvæsen. </p>
<p>Børn og unge 
Denne medicin må ikke gives til børn eller unge under 18 år. </p>
<p>Brug af anden medicin sammen med Enurev Breezhaler 
Fortæl altid lægen eller apotekspersonalet, hvis du bruger anden medicin eller har gjort det for nylig. 
Det gælder også for medicin tilsvarende Enurev Breezhaler, som bruges i forbindelse med din 
lungelidelse, f.eks. ipratropium, oxitropium eller tiotropium (såkaldte antikolinerge lægemidler). </p>
<p>Der er ikke blevet indberettet yderligere bivirkninger, når Enurev Breezhaler er blevet brugt sammen 
med anden medicin til behandling af KOL, som fx behovsinhalatorer (fx salbutamol), methylxanthiner 
(fx theophyllin) og/eller orale og inhalerede steroider (fx prednisolon). </p>
<p>Graviditet, amning og frugtbarhed 
Hvis du er gravid eller ammer, har mistanke om, at du er gravid, eller planlægger at blive gravid, skal 
du spørge din læge eller apotekspersonalet til råds, før du bruger dette lægemiddel. </p>
<p>Der er ingen data om brug af dette lægemiddel til gravide kvinder, og det vides ikke, hvorvidt det 
aktive stof i denne medicin udskilles i human mælk. </p>
<p>Trafik- og arbejdssikkerhed 
Dette lægemiddel menes ikke at påvirke evnen til at køre bil eller betjene maskiner. </p>
<p>Enurev Breezhaler indeholder lactose 
Dette lægemiddel indeholder lactose. Kontakt lægen, før du tager dette lægemiddel, hvis lægen har 
fortalt dig, at du ikke tåler visse sukkerarter. </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take enurev"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take enurev"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Brug altid lægemidlet nøjagtigt efter lægens eller apotekspersonalets anvisning. Er du i tvivl, så spørg 
lægen eller apotekspersonalet. </p>
<p>Så meget Enurev Breezhaler skal du tage 
Den sædvanlige dosis er inhalation af én kapsel dagligt. 
Du skal kun inhalere én gang dagligt, da virkningen af dette lægemiddel varer i 24 timer. 
Brug ikke mere end den dosis lægen anbefaler dig at bruge. </p>
<p>Ældre 
Du kan bruge denne medicin ved samme dosis som for andre voksne, hvis du er 75 år eller ældre. </p>
<p>Tidspunkt for inhalering af Enurev Breezhaler 
Brug dette lægemiddel på samme tidspunkt hver dag. Det hjælper dig også med at huske at tage 
medicinen. </p>
<p>Du kan inhalere denne medicin på hvilket som helst tidspunkt før og efter indtagelse af mad og drikke. </p>
<p>Sådan skal du inhalere Enurev Breezhaler 
- Denne pakning indeholder en inhalator og kapsler (i blister), som indeholder medicinen i form 
af et inhalationspulver. Brug kun kapslerne sammen med den vedlagte inhalator (Enurev 
Breezhaler-inhalator). Kapslerne skal forblive i blisteren, indtil de skal bruges. 
- Tryk ikke kapslen gennem folien. 
- Når du starter på en ny pakning, skal du bruge den nye Enurev Breezhaler-inhalator, som er 
vedlagt pakningen. 
- Smid inhalatoren i hver pakning ud efter alle kapsler i pakningen er brugt. 
- Kapslerne må ikke synkes. 
- Læs brugsanvisningen sidst i denne indlægsseddel for at få yderligere oplysninger om, hvordan 
du bruger inhalatoren. </p>
<p>Hvis du har brugt for meget Enurev Breezhaler 
Hvis du har inhaleret for meget af dette lægemiddel, eller hvis andre personer ved et uheld bruger dine 
kapsler, skal du øjeblikkeligt fortælle det til din læge eller henvende dig til den nærmeste skadestue. 
Vis dem pakken med Enurev Breezhaler. Behandling kan være nødvendig. </p>
<p>Hvis du har glemt at bruge Enurev Breezhaler 
Hvis du har glemt at inhalere en dosis, så tag den hurtigst muligt. Du må ikke tage to doser den samme 
dag. Tag derefter næste dosis til sædvanlig tid. </p>
<p>Hvor længe skal du fortsætte med Enurev Breezhaler-behandling 
- Fortsæt med at bruge dette lægemiddel, så længe din læge siger, at du skal gøre det. 
- KOL er en kronisk sygdom, og du skal bruge dette lægemiddel hver dag og ikke blot, når du har 
åndedrætsbesvær eller andre symptomer på KOL. 
Hvis du har spørgsmål om, hvor lang tid du skal fortsætte din behandling med dette lægemiddel, skal 
du tale med din læge eller apotekspersonalet. </p>
<p>Spørg lægen, apotekspersonalet eller sygeplejersken, hvis der er noget, du er i tvivl om. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Dette lægemiddel kan som alle andre lægemidler give bivirkninger, men ikke alle får bivirkninger. </p>
<p>Nogle bivirkninger kan være alvorlige og er ikke almindelige 
(kan forekomme hos flere end 1 ud af 100 patienter) </p>
<ul>
<li>
<p>Uregelmæssig hjerterytme </p>
</li>
<li>
<p>Højt blodsukkerniveau (hyperglykæmi: sædvanlige symptomer er overdreven tørst eller sult og 
hyppig vandladning) </p>
</li>
<li>
<p>Udslæt, kløe, nældefeber, problemer med at trække vejret eller synke, svimmelhed (mulige tegn 
på allergisk reaktion) </p>
</li>
<li>
<p>Hævelse, hovedsagelig af tunge, læber, ansigt eller hals (mulige tegn på angioødem) 
Hvis oplever en af disse bivirkninger, skal du kontakte din læge med det samme. </p>
</li>
</ul>
<p>Nogle bivirkninger kan være alvorlige, men hyppigheden af disse bivirkninger er ikke kendt 
(hyppighed kan ikke estimeres ud fra forhåndenværende data) </p>
<ul>
<li>Vejrtrækningsbesvær med hiven efter vejret eller hoste (tegn på paradoks bronkospasme) </li>
</ul>
<p>Nogle bivirkninger er almindelige 
(kan forekomme hos flere end 1 ud af 10 patienter) </p>
<ul>
<li>
<p>Mundtørhed </p>
</li>
<li>
<p>Søvnbesvær </p>
</li>
<li>
<p>Løbende eller tilstoppet næse, nysen, ondt i halsen </p>
</li>
<li>
<p>Diare eller mavesmerter </p>
</li>
<li>
<p>Muskel- og skeletsmerter </p>
</li>
</ul>
<p>Nogle bivirkninger er ikke almindelige 
(kan forekomme hos flere end 1 ud af 100 patienter) </p>
<ul>
<li>
<p>Vanskelig og smertefuld vandladning </p>
</li>
<li>
<p>Smertefuld eller hyppig vandladning </p>
</li>
<li>
<p>Hjertebanken </p>
</li>
<li>
<p>Udslæt </p>
</li>
<li>
<p>Følelsesløshed </p>
</li>
<li>
<p>Hoste med opspyt </p>
</li>
<li>
<p>Huller i tænderne </p>
</li>
<li>
<p>En fornemmelse af trykken eller smerter i kinder og pande </p>
</li>
<li>
<p>Næseblod </p>
</li>
<li>
<p>Smerter i arme eller ben </p>
</li>
<li>
<p>Smerter i muskler, knogler eller led i brystet </p>
</li>
<li>
<p>Ubehag i maven efter måltider </p>
</li>
<li>
<p>Irritation i halsen </p>
</li>
<li>
<p>Træthed </p>
</li>
<li>
<p>Svaghed </p>
</li>
<li>
<p>Kløe </p>
</li>
<li>
<p>Ændring af stemmen (hæshed) </p>
</li>
<li>
<p>Kvalme </p>
</li>
<li>
<p>Opkastning </p>
</li>
</ul>
<p>Visse ældre patienter over 75 år kan opleve hovedpine (almindeligt forekommende) og 
urinvejsinfektion (almindeligt forekommende). </p>
<p>Indberetning af bivirkninger 
Hvis du oplever bivirkninger, bør du tale med din læge eller apotekspersonalet. Dette gælder også 
mulige bivirkninger, som ikke er medtaget i denne indlægsseddel. Du eller dine pårørende kan også 
indberette bivirkninger direkte til Lægemiddelstyrelsen via det nationale rapporteringssystem anført i 
Appendiks V. Ved at indrapportere bivirkninger kan du hjælpe med at fremskaffe mere information 
om sikkerheden af dette lægemiddel. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store enurev"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store enurev"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Opbevar lægemidlet utilgængeligt for børn. </p>
<p>Brug ikke lægemidlet efter den udløbsdato, der står på pakningen og blisteren efter "EXP". 
Udløbsdatoen er den sidste dag i den nævnte måned. </p>
<p>Må ikke opbevares ved temperaturer over 25 °C. </p>
<p>Opbevar kapslerne i den originale blister for at beskytte mod fugt. Må først tages ud af blisteren lige 
før brug. </p>
<p>Smid inhalatoren i hver pakning ud når alle kapsler i pakningen er brugt. </p>
<p>Brug ikke lægemidlet, hvis du bemærker at pakningen er beskadiget eller viser tegn på at have været 
åbnet. </p>
<p>Spørg på apotekspersonalet, hvordan du skal bortskaffe medicinrester. Af hensyn til miljøet må du 
ikke smide medicinrester i afløbet eller skraldespanden. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Enurev Breezhaler indeholder 
- Aktivt stof: glycopyrroniumbromid. Hver kapsel indeholder 63 mikrogram 
glycopyrroniumbromid (svarende til 50 mikrogram glycopyrronium). Leveret dosis (den dosis, 
som afgives fra mundstykket af inhalatoren) svarer til 44 mikrogram glycopyrronium. 
- Øvrige indholdsstoffer i inhalationspulveret: lactosemonohydrat og magnesiumstearat. </p>
<p>Udseende og pakningsstørrelser 
Enurev Breezhaler 44 mikrogram inhalationspulver, hårde kapsler er gennemsigtige og orange og 
indeholder et hvidt pulver. De har påtrykt en sort produktkode "GPL50" over og virksomhedens logo (
) er påtrykt i sort under en sort bjælke. </p>
<p>Hver pakning indeholder en inhalator, samt kapsler i blister. Hvert blisterkort indeholder enten 6 eller 
10 hårde kapsler. </p>
<p>Følgende pakningsstørrelser er tilgængelige: 
Pakninger med 6 x 1, 10 x 1, 12 x 1 og 30 x 1 kapsler og 1 inhalator. </p>
<p>Multipakning bestående af 90 kapsler (3 pakninger af 30 x 1) og 3 inhalatorer. 
Multipakning bestående af 96 kapsler (4 pakninger af 24 x 1) og 4 inhalatorer. 
Multipakning bestående af 150 kapsler (15 pakninger af 10 x 1) og 15 inhalatorer. 
Multipakning bestående af 150 kapsler (25 pakninger af 6 x 1) og 25 inhalatorer. </p>
<p>Ikke alle pakningsstørrelser er nødvendigvis markedsført i dit land. </p>
<p>Indehaver af markedsføringstilladelsen 
Novartis Europharm Limited 
Vista Building 
Elm Park, Merrion Road 
Dublin 4 
Irland </p>
<p>Fremstiller 
Novartis Farmacéutica SA 
Gran Via de les Corts Catalanes, 08013 Barcelona 
Spanien </p>
<p>Novartis Pharma GmbH 
Roonstraße D-90429 Nürnberg 
Tyskland </p>
<p>Hvis du ønsker yderligere oplysninger om dette lægemiddel, skal du henvende dig til den lokale 
repræsentant for indehaveren af markedsføringstilladelsen: </p>
<p>België/Belgique/Belgien 
Novartis Pharma N.V. 
Tél/Tel: +32 2 246 16<br />
Lietuva 
SIA Novartis Baltics Lietuvos filialas 
Tel: +370 5 269 16<br />
България 
Novartis Bulgaria EOOD 
Тел.: +359 2 489 98<br />
Luxembourg/Luxemburg 
Novartis Pharma N.V. 
Tél/Tel: +32 2 246 16<br />
Česká republika 
Novartis s.r.o. 
Tel: +420 225 775<br />
Magyarország 
Novartis Hungária Kft. 
Tel.: +36 1 457 65 Danmark 
Novartis Healthcare A/S 
Tlf: +45 39 16 84<br />
Malta 
Novartis Pharma Services Inc. 
Tel: +356 2122 2Deutschland 
Novartis Pharma GmbH 
Tel: +49 911 273 0 </p>
<p>Nederland 
Novartis Pharma B.V. 
Tel: +31 88 04 52 Eesti 
SIA Novartis Baltics Eesti filiaal 
Tel: +372 66 30<br />
Norge 
Novartis Norge AS 
Tlf: +47 23 05 20 Ελλάδα 
Novartis (Hellas) A.E.B.E. 
Τηλ: +30 210 281 17<br />
Österreich 
Novartis Pharma GmbH 
Tel: +43 1 86 6España 
Ferrer Internacional, S.A. 
Tel: +34 93 600 37<br />
Polska 
Novartis Poland Sp. z o.o. 
Tel.: +48 22 375 4France 
Novartis Pharma S.A.S. 
Tél: +33 1 55 47 66<br />
Portugal 
Novartis Farma - Produtos Farmacêuticos, S.A. 
Tel: +351 21 000 8Hrvatska 
Novartis Hrvatska d.o.o. 
Tel. +385 1 6274<br />
România 
Novartis Pharma Services Romania SRL 
Tel: +40 21 31299 Ireland 
Novartis Ireland Limited 
Tel: +353 1 260 12<br />
Slovenija 
Novartis Pharma Services Inc. 
Tel: +386 1 300 75 Ísland 
Vistor hf. 
Sími: +354 535 7 
Slovenská republika 
Novartis Slovakia s.r.o. 
Tel: +421 2 5542 5 
Italia 
Novartis Farma S.p.A. 
Tel: +39 02 96 54 1 
Suomi/Finland 
Novartis Finland Oy 
Puh/Tel: +358 (0)10 6133<br />
Κύπρος 
Novartis Pharma Services Inc. 
Τηλ: +357 22 690<br />
Sverige 
Novartis Sverige AB 
Tel: +46 8 732 32<br />
Latvija 
SIA Novartis Baltics 
Tel: +371 67 887<br />
United Kingdom (Northern Ireland) 
Novartis Ireland Limited 
Tel: +44 1276 698 </p>
<p>Denne indlægsseddel blev senest ændret </p>
<p>Andre informationskilder 
Du kan finde yderligere oplysninger om dette lægemiddel på Det Europæiske Lægemiddelagenturs 
hjemmeside http://www.ema.europa.eu </p>
<p>Brugsanvisning til Enurev Breezhaler-inhalator </p>
<p>Læs venligst den fulde anvisning for brug inden du bruger Enurev Breezhaler. </p>
<p>Læg en kapsel i 
Perforer og slip 
Inhaler dybt 
Tjek, at kapslen er tom </p>
<p>Trin 1a: 
Fjern hætten 
Trin 2a: 
Perforer kapslen én 
gang 
Hold inhalatoren lodret. 
Perforer kapslen ved 
samtidigt at trykke begge 
sideknapper helt ind. 
Trin 3a: 
Tag en dyb udånding 
Du må ikke puste i 
mundstykket. 
Tjek, at kapslen er tom 
Åben inhalatoren for at 
kontrollere, om der er 
overskydende pulver i 
kapslen. </p>
<p>Du vil høre et klik, når 
kapslen perforeres. 
Perforer kun kapslen én 
gang. </p>
<p>Hvis der er overskydende 
pulver i kapslen: </p>
<ul>
<li>
<p>Luk inhalatoren. </p>
</li>
<li>
<p>Gentag trin 3a til 3c. 
Trin 1b: 
Åben inhalatoren </p>
</li>
</ul>
<p>Trin 2b: 
Slip sideknapperne helt 
Trin 3b: 
Inhaler medicinen dybt 
Hold inhalatoren som 
vist på billedet. Tag 
mundstykket i munden, 
og luk læberne tæt 
omkring det. 
Tryk ikke på 
sideknapperne. </p>
<p>Overskydende 
Tom 
pulver 
1 
2 
3 
Tjek </p>
<p>Tag en hurtig og så dyb 
indånding som muligt. 
Under inhalationen vil du 
høre en snurrende lyd. 
Du kan muligvis smage 
medicinen mens du 
inhalerer. </p>
<p>Trin 1c: 
Fjern kapslen 
Adskil en blister fra 
blisterkortet. 
Åbn blisteren og fjern 
kapslen. 
Tryk ikke kapslen gennem 
folien. 
Kapslen må ikke synkes. </p>
<p>Trin 3c: 
Hold vejret 
Hold vejret i op til 
5 sekunder. 
Fjern den tomme kapsel 
Smid kapslen ud sammen 
med almindeligt 
husholdningsaffald. 
Luk inhalatoren, og sæt 
hætten på igen. </p>
<p>Trin 1d: 
Læg kapslen i 
kapselkammeret 
Læg aldrig en kapsel 
direkte i mundstykket. </p>
<p>Vigtig information 
• Enurev Breezhaler 
kapsler skal altid 
opbevares i den originale 
blister og må først tages 
ud umiddelbart inden 
anvendelse. 
• Tryk ikke kapslen 
gennem folien for at 
fjerne den fra 
blisterkortet. 
• Kapslerne må ikke 
synkes. 
• Brug ikke Enurev 
Breezhaler kapsler med 
nogen anden inhalator. 
• Brug ikke Enurev 
Breezhaler inhalatoren 
til at tage anden kapsel-
medicin. 
• Læg aldrig kapslen 
direkte i munden eller i 
inhalatorens 
mundstykke. 
• Tryk ikke på 
sideknapperne mere end 
én gang. 
• Pust ikke ind i 
mundstykket. 
• Tryk ikke på 
sideknapperne mens du 
inhalerer gennem 
mundstykket. 
• Håndter ikke kapslerne 
med fugtige hænder. 
• Vask aldrig din inhalator 
med vand. </p>
<p>Trin 1e: 
Luk inhalatoren </p>
<p>Din Enurev Breezhaler inhalatorpakning indeholder: 
• En Enurev Breezhaler inhalator 
• Et eller flere blisterkort, som hver indeholder 
enten 6 eller 10 Enurev Breezhaler kapsler til 
brug i inhalatoren </p>
<p>Ofte stillede spørgsmål </p>
<p>Hvorfor lavede 
inhalatoren ikke en lyd 
da jeg inhalerede? 
Kapslen kan muligvis 
sidde fast i kammeret. 
Hvis dette er tilfældet, skal 
du forsigtigt løsne kapslen 
ved at banke let på 
inhalatorens underdel. 
Inhaler medicinen igen ved 
at gentage trin 3a til 3c. </p>
<p>Hvad skal jeg gøre, hvis 
der er overskydende 
pulver i kapslen? 
Du har ikke fået en 
tilstrækkeligt mængde af 
din medicin. Luk 
inhalatoren og gentag 
trin 3a til 3c. </p>
<p>Jeg hostede efter jeg 
inhalerede - betyder det 
noget? 
Dette kan forekomme. Så 
længe kapslen er tom, har 
du fået en tilstrækkelig 
mængde af din medicin. </p>
<p>Jeg kunne mærke små 
stykker af kapslen på 
min tunge - betyder det 
noget? 
Dette kan forekomme, og 
det er ikke farligt. 
Risikoen for at kapslen går 
i små stykker forøges, hvis 
kapslen perforeres mere 
end én gang. 
Rengøring af inhalatoren 
Tør inderside og yderside 
af mundstykket med en 
ren, tør og fnugfri klud for 
at fjerne eventuelle 
pulverrester. Hold 
inhalatoren tør. Vask 
aldrig din inhalator med 
vand. 
Bortskaffelse af inhalator 
efter brug 
Hver inhalator skal 
bortskaffes efter alle 
kapslerne er brugt. Spørg 
på apoteket hvordan du 
skal bortskaffe medicin og 
inhalatorer, som du ikke 
længere har behov for. </p>
<p>Blisterkort 
Blister 
Inhalatorunderdel 
Inhalator 
Underdel 
Hætte 
Sideknapper 
Kapselkammer 
Mundstykke 
Gitter </p>         </div>"""      





                    
Instance: bundlepackageleaflet-en-91e2d101c3ad773f6da87d4465331140
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for enurev Package Leaflet for language en"
Description: "ePI document Bundle for enurev Package Leaflet for language en"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #en

// Composition
* entry[0].fullUrl = "Composition/composition-en-91e2d101c3ad773f6da87d4465331140"
* entry[0].resource = composition-en-91e2d101c3ad773f6da87d4465331140

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mp91e2d101c3ad773f6da87d4465331140"
* entry[=].resource = mp91e2d101c3ad773f6da87d4465331140
                            
                    
Instance: bundlepackageleaflet-da-91e2d101c3ad773f6da87d4465331140
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for enurev Package Leaflet for language da"
Description: "ePI document Bundle for enurev Package Leaflet for language da"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #da

// Composition
* entry[0].fullUrl = "Composition/composition-da-91e2d101c3ad773f6da87d4465331140"
* entry[0].resource = composition-da-91e2d101c3ad773f6da87d4465331140

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mp91e2d101c3ad773f6da87d4465331140"
* entry[=].resource = mp91e2d101c3ad773f6da87d4465331140
                            
                    



Instance: mp91e2d101c3ad773f6da87d4465331140
InstanceOf: MedicinalProductDefinitionUvEpi
Title: "Medicinal Product Enurev Breezhaler 44 micrograms inhalation powder, hard capsules"
Description: "Enurev Breezhaler 44 micrograms inhalation powder, hard capsules"
Usage: #inline

 
* identifier[+].system = "http://ema.europa.eu/identifier"
* identifier[=].value = "EU/1/12/789/001-008"
* type = http://hl7.org/fhir/medicinal-product-type#MedicinalProduct "Medicinal Product"

* domain = http://hl7.org/fhir/medicinal-product-domain#Human "Human use"

* status = http://hl7.org/fhir/publication-status#active "active"



* legalStatusOfSupply = $spor-rms#100000072084 "Medicinal product subject to medical prescription"

* name
  * productName = "Enurev Breezhaler 44 micrograms inhalation powder, hard capsules"
  * type = $spor-productNamePartType-cs#220000000001 "Full name" 
  
  * part[0]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000002 "Invented name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000003 "Scientific name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000004 "Strength part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000005 "Pharmaceutical dose form part"
  
  * usage
    * country = urn:iso:std:iso:3166#EU "EU"
    * jurisdiction = urn:iso:std:iso:3166#EU "EU"
    * language = urn:ietf:bcp:47#en  "en"



RuleSet: 91e2d101c3ad773f6da87d4465331140ListRuleset

* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* identifier[+].system = "http://spor.ema.europa.eu/v2/medicine-name"
* identifier[=].value = "enurev"

* status = #current
* mode = #working

* title = "List of all ePIs associated with enurev"

* subject = Reference(mp29cfa45e92e84ebeea3fcb2b59136717)
* subject.extension[0].url = "http://ema.europa.eu/fhir/extension/medicine-name"
* subject.extension[=].valueCoding = $100000000005#enurev "enurev"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/marketing-authorization-holder"
* subject.extension[=].valueCoding = $100000000005#mah-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/active-substance"
* subject.extension[=].valueCoding = $100000000005#acive-substance-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/domain"
* subject.extension[=].valueCoding = $100000000004#100000000012 "H"

* date = "2015-02-07T13:28:17Z"


* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-en-91e2d101c3ad773f6da87d4465331140) // enurev en
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "en"



* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-da-91e2d101c3ad773f6da87d4465331140) // enurev da
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "da"




Instance: List-91e2d101c3ad773f6da87d4465331140
InstanceOf: List

* insert 91e2d101c3ad773f6da87d4465331140ListRuleset
    